UNSPSC 51142560: Phenglutarimide hydrochloride

This classification denotes an anticholinergic agent with the molecular formula C17H24N2O2.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier B963BYQ21V, chemically known as 2-(2-diethylaminoethyl)-2-phenylglutarimide hydrochloride, but more generally known as phenglutarimide hydrochloride, which bears US NIH Compound Identifier 102668. European Medicines Agency schedules phenglutarimide hydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09762MIG.

Most nations, for tariff purposes, schedule phenglutarimide hydrochloride under HS 29251995. SMILES: CCN(CC)CCC1(CCC(=O)NC1=O)C2CCCCC2.CL.

UNSPSC 51142560 Phenglutarimide hydrochloride is a Commodity code that describes pharmaceutical compounds used in specialized medical and public health applications. Recent state and local solicitations under this code show procurement of naloxone and drug deactivation systems for community health and emergency response. The issuing bodies are county health departments and government purchasing offices acquiring these products to support public health initiatives, particularly opioid-overdose response and controlled-substance management programs.

Seminole County, Florida posted IFB60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems through competitive sealed bidding, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2026. The contract includes a two-year initial term with a one-year renewal option, fixed-fee pricing, E-Verify compliance, and potential FEMA funding. The source contains only one recent opportunity; geographic concentration and repeat issuing-body patterns cannot be established from the available data.